Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T38.906ABillable
Underdosing of unspecified hormone antagonists, initial encounter
- T38.906DBillable
Underdosing of unspecified hormone antagonists, subsequent encounter
- T38.906SBillable
Underdosing of unspecified hormone antagonists, sequela
- T38.995ABillable
Adverse effect of other hormone antagonists, initial encounter
- T38.995DBillable
Adverse effect of other hormone antagonists, subsequent encounter
- T38.995SBillable
Adverse effect of other hormone antagonists, sequela
- T38.996ABillable
Underdosing of other hormone antagonists, initial encounter
- T38.996DBillable
Underdosing of other hormone antagonists, subsequent encounter
- T38.996SBillable
Underdosing of other hormone antagonists, sequela
- T39.015ABillable
Adverse effect of aspirin, initial encounter
- T39.015DBillable
Adverse effect of aspirin, subsequent encounter
- T39.015SBillable
Adverse effect of aspirin, sequela
- T39.016ABillable
Underdosing of aspirin, initial encounter
- T39.016DBillable
Underdosing of aspirin, subsequent encounter
- T39.016SBillable
Underdosing of aspirin, sequela
- T39.095ABillable
Adverse effect of salicylates, initial encounter
- T39.095DBillable
Adverse effect of salicylates, subsequent encounter
- T39.095SBillable
Adverse effect of salicylates, sequela
- T39.096ABillable
Underdosing of salicylates, initial encounter
- T39.096DBillable
Underdosing of salicylates, subsequent encounter
- T39.096SBillable
Underdosing of salicylates, sequela
- T39.1X5ABillable
Adverse effect of 4-Aminophenol derivatives, initial encounter
- T39.1X5DBillable
Adverse effect of 4-Aminophenol derivatives, subsequent encounter
- T39.1X5SBillable
Adverse effect of 4-Aminophenol derivatives, sequela
- T39.1X6ABillable
Underdosing of 4-Aminophenol derivatives, initial encounter
- T39.1X6DBillable
Underdosing of 4-Aminophenol derivatives, subsequent encounter
- T39.1X6SBillable
Underdosing of 4-Aminophenol derivatives, sequela
- T39.2X5ABillable
Adverse effect of pyrazolone derivatives, initial encounter
- T39.2X5DBillable
Adverse effect of pyrazolone derivatives, subsequent encounter
- T39.2X5SBillable
Adverse effect of pyrazolone derivatives, sequela
- T39.2X6ABillable
Underdosing of pyrazolone derivatives, initial encounter
- T39.2X6DBillable
Underdosing of pyrazolone derivatives, subsequent encounter
- T39.2X6SBillable
Underdosing of pyrazolone derivatives, sequela
- T39.315ABillable
Adverse effect of propionic acid derivatives, initial encounter
- T39.315DBillable
Adverse effect of propionic acid derivatives, subsequent encounter
- T39.315SBillable
Adverse effect of propionic acid derivatives, sequela
- T39.316ABillable
Underdosing of propionic acid derivatives, initial encounter
- T39.316DBillable
Underdosing of propionic acid derivatives, subsequent encounter
- T39.316SBillable
Underdosing of propionic acid derivatives, sequela
- T39.395ABillable
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
- T39.395DBillable
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
- T39.395SBillable
Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
- T39.396ABillable
Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
- T39.396DBillable
Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
- T39.396SBillable
Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
- T39.4X5ABillable
Adverse effect of antirheumatics, not elsewhere classified, initial encounter
- T39.4X5DBillable
Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter
- T39.4X5SBillable
Adverse effect of antirheumatics, not elsewhere classified, sequela
- T39.4X6ABillable
Underdosing of antirheumatics, not elsewhere classified, initial encounter
- T39.4X6DBillable
Underdosing of antirheumatics, not elsewhere classified, subsequent encounter
- T39.4X6SBillable
Underdosing of antirheumatics, not elsewhere classified, sequela
- T39.8X5ABillable
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
- T39.8X5DBillable
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
- T39.8X5SBillable
Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
- T39.8X6ABillable
Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
- T39.8X6DBillable
Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
- T39.8X6SBillable
Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
- T39.95XABillable
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
- T39.95XDBillable
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
- T39.95XSBillable
Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
- T39.96XABillable
Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
- T39.96XDBillable
Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
- T39.96XSBillable
Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
- T40.0X5ABillable
Adverse effect of opium, initial encounter
- T40.0X5DBillable
Adverse effect of opium, subsequent encounter
- T40.0X5SBillable
Adverse effect of opium, sequela
- T40.0X6ABillable
Underdosing of opium, initial encounter
- T40.0X6DBillable
Underdosing of opium, subsequent encounter
- T40.0X6SBillable
Underdosing of opium, sequela
- T40.2X5ABillable
Adverse effect of other opioids, initial encounter
- T40.2X5DBillable
Adverse effect of other opioids, subsequent encounter
- T40.2X5SBillable
Adverse effect of other opioids, sequela
- T40.2X6ABillable
Underdosing of other opioids, initial encounter
- T40.2X6DBillable
Underdosing of other opioids, subsequent encounter
- T40.2X6SBillable
Underdosing of other opioids, sequela
- T40.3X5ABillable
Adverse effect of methadone, initial encounter
- T40.3X5DBillable
Adverse effect of methadone, subsequent encounter
- T40.3X5SBillable
Adverse effect of methadone, sequela
- T40.3X6ABillable
Underdosing of methadone, initial encounter
- T40.3X6DBillable
Underdosing of methadone, subsequent encounter
- T40.3X6SBillable
Underdosing of methadone, sequela
- T40.415ABillable
Adverse effect of fentanyl or fentanyl analogs, initial encounter
- T40.415DBillable
Adverse effect of fentanyl or fentanyl analogs, subsequent encounter
- T40.415SBillable
Adverse effect of fentanyl or fentanyl analogs, sequela
- T40.416ABillable
Underdosing of fentanyl or fentanyl analogs, initial encounter
- T40.416DBillable
Underdosing of fentanyl or fentanyl analogs, subsequent encounter
- T40.416SBillable
Underdosing of fentanyl or fentanyl analogs, sequela
- T40.425ABillable
Adverse effect of tramadol, initial encounter
- T40.425DBillable
Adverse effect of tramadol, subsequent encounter
- T40.425SBillable
Adverse effect of tramadol, sequela
- T40.426ABillable
Underdosing of tramadol, initial encounter
- T40.426DBillable
Underdosing of tramadol, subsequent encounter
- T40.426SBillable
Underdosing of tramadol, sequela
- T40.495ABillable
Adverse effect of other synthetic narcotics, initial encounter
- T40.495DBillable
Adverse effect of other synthetic narcotics, subsequent encounter
- T40.495SBillable
Adverse effect of other synthetic narcotics, sequela
- T40.496ABillable
Underdosing of other synthetic narcotics, initial encounter
- T40.496DBillable
Underdosing of other synthetic narcotics, subsequent encounter
- T40.496SBillable
Underdosing of other synthetic narcotics, sequela
- T40.5X5ABillable
Adverse effect of cocaine, initial encounter
